Pension Fund

Updated:

Cedars-Sinai Medical Center (Defined Contribution)

Cedars-Sinai Medical Center established its defined contribution plan to manage employee retirement savings. Pasy Wang serves as chief investment officer with...

Cedars-Sinai Medical Center (Defined Contribution)

Cedars-Sinai Medical Center established its defined contribution plan to manage employee retirement savings. Pasy Wang serves as chief investment officer with responsibility for the plan alongside other hospital investment pools. No public founding date for the plan itself appears in available records. The plan allocates across short-term investment funds and core options that include mutual funds and collective investment trusts. Confirmed positions include holdings in healthcare companies such as Capricor Therapeutics and Prometheus Biosciences. Geographic exposure centers on the United States with additional venture commitments through Cedars-Sinai Health Ventures. The investment office maintains an administrative location at 6500 Wilshire Blvd in Los Angeles. Pasy Wang participates in industry events including the Endowments & Foundations Roundtable. Brian Chen supports investment management as managing director. The plan sits inside the larger 501(c)(3) hospital structure, which also maintains a fine art collection and multiple real estate holdings including the main campus and Marina Del Rey Hospital project.

General information

Firm type

Pension Fund

Year founded

1974

Location

Region

North America

Country

United States

City

Los Angeles

Principals

Pasy Wang

Chief Investment Officer

Brian Chen

Managing Director, Investments

Sector focus

Healthcare

Frequently asked questions

Who runs investment decisions at Cedars-Sinai Medical Center (Defined Contribution)?

Pasy Wang serves as chief investment officer and oversees the plan. Brian Chen acts as managing director of investments.

What liquidity terms apply to the plan?

Most core investment options offer daily liquidity through mutual funds and collective investment trusts.

Does the plan hold public equity positions?

Yes. Reported holdings include a 10 percent stake in Capricor Therapeutics and a position in Prometheus Biosciences.

How does the plan relate to Cedars-Sinai Health Ventures?

The plan participates in venture investments through Cedars-Sinai Health Ventures in companies such as Vista.ai and Regard.

What is the plan's primary geographic focus?

Investments center on the United States with some exposure to Canadian companies such as Paperplane Therapeutics.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on pension funds?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Los Angeles Pension Fund profiles